BACKGROUND: The presence of multiple melanocytic naevi is a strong risk factor for melanoma. Use of the whole body naevus count to identify at-risk patients is impractical. OBJECTIVES: To (i) identify a valid anatomical predictor of total naevus count; (ii) determine the number of naevi that most accurately predict total naevus count above 25, 50 and 100; and (iii) evaluate determinants of multiple melanocytic naevi and atypical naevi. METHODS: Clinical data from 292 consecutive Spanish patients consulting for skin lesions requiring debriding were collected throughout 2009 and 2010. Correlations between site-specific and whole body naevus counts were analysed. Cut-offs to predict total naevus counts were determined using the area under the ...
Cutaneous melanoma incidence continues to rise, imposing a sizable burden on health services and soc...
Background. The incidence of cutaneous melanoma is rapidly increasing in Europe. Active research is ...
Background: There is no data about melanocytic lesions in Turkish patients with melanoma. We aimed t...
Patients with a high total nevus count (TNC) merit a total-body examination, but a simple strategy t...
Patients with a high total nevus count (TNC) merit a total-body examination, but a simple strategy t...
The number of melanocytic nevi is the strongest risk factor for cutaneous melanoma. As pigmented ski...
The risk of cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi. Sca...
The number of melanocytic nevi is the strongest risk factor for cutaneous melanoma. As pigmented ski...
The risk of cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi. Sca...
A large number of benign melanocytic nevi is the major risk factor for malignant melanoma (MM). In a...
Objectives: (1) To assess the incidence of melanoma in a cohort of patients with dysplastic melanocy...
Background: Cutaneous melanoma accounts for the majority of skin cancer-related deaths. Readily iden...
Context: Number of nevi is a risk factor for melanoma and basal cell carcinoma. Studies suggest that...
Scanty information is available on the relation between nevus count on specific anatomic areas and t...
BACKGROUND/OBJECTIVES: Melanoma may develop de novo or naevus associated (NAM). The exact prevalence...
Cutaneous melanoma incidence continues to rise, imposing a sizable burden on health services and soc...
Background. The incidence of cutaneous melanoma is rapidly increasing in Europe. Active research is ...
Background: There is no data about melanocytic lesions in Turkish patients with melanoma. We aimed t...
Patients with a high total nevus count (TNC) merit a total-body examination, but a simple strategy t...
Patients with a high total nevus count (TNC) merit a total-body examination, but a simple strategy t...
The number of melanocytic nevi is the strongest risk factor for cutaneous melanoma. As pigmented ski...
The risk of cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi. Sca...
The number of melanocytic nevi is the strongest risk factor for cutaneous melanoma. As pigmented ski...
The risk of cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi. Sca...
A large number of benign melanocytic nevi is the major risk factor for malignant melanoma (MM). In a...
Objectives: (1) To assess the incidence of melanoma in a cohort of patients with dysplastic melanocy...
Background: Cutaneous melanoma accounts for the majority of skin cancer-related deaths. Readily iden...
Context: Number of nevi is a risk factor for melanoma and basal cell carcinoma. Studies suggest that...
Scanty information is available on the relation between nevus count on specific anatomic areas and t...
BACKGROUND/OBJECTIVES: Melanoma may develop de novo or naevus associated (NAM). The exact prevalence...
Cutaneous melanoma incidence continues to rise, imposing a sizable burden on health services and soc...
Background. The incidence of cutaneous melanoma is rapidly increasing in Europe. Active research is ...
Background: There is no data about melanocytic lesions in Turkish patients with melanoma. We aimed t...